New Releases from NCBI BookshelfCabozantinib for Second-Line Treatment of Advanced or Metastatic Renal Cell Carcinoma: Drugs [Internet].​Cabozantinib for Second-Line Treatment of Advanced or Metastatic Renal Cell Carcinoma: Drugs [Internet].

By /

Immune checkpoint inhibitor–based therapies, especially dual immune checkpoint inhibitor regimens, are now frequently used as initial treatments for advanced or metastatic renal cell carcinoma (RCC).

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Useful Links

NEWREDMARS SKILL AND RESEARCH        FOUNDATION

Registration No: 771800548      Contact Number : +91-8249516996

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Scroll to Top